Although medical device companies continue to be careful with their budgets, they are still on watch and are making room for strategic acquisitions that will bring a big boost to their portfolios. In a brief interview with MedTech Intelligence, Karl Freimuth, partner and co-head of the U.S. industrials practice at Livingstone, an independent M&A and advisory firm, expands on his latest report, “2018 Year in Review & 2019 Outlook” and what he sees as key industry drivers, challenges and opportunities.
Industry Challenges
Skilled labor shortage—this is pervasive more broadly in the U.S. manufacturing industry
Current low unemployment rates
Both of the above factors are causing businesses to struggle to find the right people to keep up with the demand from OEMs
On a positive note, these challenges are prompting contract manufacturers to invest in capital and technology to increase efficiencies in workflow and production. “I think part of the labor shortage is actually driving production innovations on the plant floor,” said Freimuth.
Areas of Growth
Robotic surgery and minimally invasive surgery is strong. The robotic surgery market is experiencing “explosive” growth in the 20+% annual range. “J&J just announced its investment in Auris [Health], which is another surgical robotic platform that was started by the former founder of Intuitive Surgical [Frederic Moll, M.D.], which is the largest robotic surgery platform globally,” said Freimuth. “That market continues to grow at a rapid pace. At med schools, surgeons are being taught on robotic surgical platforms. Data indicates that patient outcomes, safety and recovery times are being reduced; it’s more cost efficient for the hospital systems. I think that is a high growth trend within the surgical treatment of patients.”
Artificial heart segment: Ventricular assist devices are helping patients live longer without requiring a heart transplant. The market continues to see a demand with the pervasive nature of heart disease in the aging demographic. This cardiovascular technology segment is experiencing high single-digit to mid-teens annual growth.
Other growth areas include POC testing, stents, clot retrieval devices, diabetes management technology, orthopedic implants, devices that treat atrial fibrillation, TAVR, spinal cord therapeutic technology and remote monitoring
Deals & Acquisitions
OEMs are making significant investments in internal R&D and are deploying capital to make acquisitions
OEMs and contract manufacturers are engaging in M&A activity. “There is a continued pent-up demand for acquisition activity at the tail end of this eight- or nine-year bull run we’re fielding. There are assets coming to market in 2019 ahead of the 2020 presidential cycle, and with major acquirers performing well and continuing to grow, they’re seeking acquisitions to continue building their platforms,” says Freimuth.
Industry consolidation on the part of OEMs and contract manufacturers has changed the landscape. “If small- to mid-market business owners (device manufacturers or outsourced contract manufacturing partners) aren’t investing in engineering talent, additional capital equipment, and facility expansions to keep pace with the growth of the industry, they run the risk of having their businesses tail off and lose their position on platforms as they sunset. There is clear momentum in the industry for a continued strong year in terms of middle market exits both at the contract manufacturing level as well as the OEM level.”
Medical device OEMs prefer to acquire proven technologies to fill portfolio gaps and “plug-and-play” into their global sales and marketing infrastructure.
Some OEMs continue to be skittish towards investing in nascent, high-risk technology that isn’t FDA approved
It is more important than ever for medical manufacturers to prepare for business interruption due to unexpected damage or natural disasters. From building a recovery team to securing proper insurance, there are many steps device manufacturers can take to recover…
Double-digit growth of the company’s literature review software platform, DistillerSR, spurred $20 million in funding from the growth investment consortium led by Thomvest Ventures.
Nondisclosure agreements (NDAs) can help protect trade secrets and build a framework for better cooperation and understanding between parties. Following are some key areas to consider when creating an NDA.
Maria Fontanazza has more than 15 years of experience in journalism, marketing and communications. She was previously marketing communications manager and market research manager at Secant Medical, Inc., a manufacturer of biomedical textiles and advanced biomaterials. Fontanazza also served as an editor at MD+DI and has authored articles that have appeared in domestic and international industry publications. Fontanazza has a B.A. in Journalism and Mass Communications with a concentration in New Media and Visual Design, and a Minor in Fine Arts, from St. Michael’s College in Colchester, VT. Follow her industry insights on Twitter at @MariaFontanazza. Contact Maria